Although hypoxia is a key regulator of tumour invasion by activating the transcriptional regulators hypoxia-inducible factors, HIF-1α and HIF-2α (refs 16, 17), the molecular machinery behind evasive resistance in solid tumours following anti-angiogenic therapy is insufficiently understood. The gene discussed is HIF1A; the disease is neoplasm.